Nature Biotechnology

• 

  Publication Venue For

  • A genomic catalog of Earth's microbiomes..  39:499-509. 2021
  • Author Correction: A genomic catalog of Earth's microbiomes..  39:521. 2021
  • Jumping at the chance for precise DNA integration..  37:1004-1006. 2019
  • Author Correction: A recellularized human colon model identifies cancer driver genes..  37:820. 2019
  • Increasing the specificity of CRISPR systems with engineered RNA secondary structures..  37:657-666. 2019
  • Functional interrogation and mining of natively paired human VH:VL antibody repertoires..  36:152-155. 2018
  • A recellularized human colon model identifies cancer driver genes..  34:845-851. 2016
  • Cas9 loosens its grip on off-target sites..  34:298-299. 2016
  • Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting..  33:656-660. 2015
  • Erratum: Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis (Nature Biotechnology (2012) 30 (1217-1224)).  31:565. 2013
  • Efficient and specific gene knockdown by small interfering RNAs produced in bacteria..  31:350-356. 2013
  • Hybrid error correction and de novo assembly of single-molecule sequencing reads..  30:693-700. 2012
  • B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study..  30:423-433. 2012
  • Verification of systems biology research in the age of collaborative competition..  29:811-815. 2011
  • Letter to editor.  28:1243. 2010
  • DNA patents and diagnostics: not a pretty picture..  28:784-791. 2010
  • Broad-spectrum defense against plant pathogens..  28:330-331. 2010
  • A kernel for the Tropical Disease Initiative..  27:320-321. 2009
  • DNA sequence patents are not in the grave yet..  27:122. 2009
  • Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins..  27:140-144. 2009
  • Folate fortification of rice by metabolic engineering..  25:1277-1279. 2007
  • The metabolomics standards initiative..  25:846-848. 2007
  • Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras..  24:1005-1015. 2006
  • AAV does the shuffle..  24:158-160. 2006
  • The licensing of DNA patents by US academic institutions: an empirical survey..  24:31-39. 2006
  • Life, diversity and the pursuit of haplotypes..  23:1376-1377. 2005
  • Islets for all?.  23:1231-1232. 2005
  • Reverse engineering gene regulatory networks..  23:554-555. 2005
  • Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity..  23:344-348. 2005
  • Antidote-mediated control of an anticoagulant aptamer in vivo..  22:1423-1428. 2004
  • Alternative splicing in disease and therapy..  22:535-546. 2004
  • Mending the message..  21:1448-1449. 2003
  • Multicolor in vitro translation..  21:1093-1097. 2003
  • Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression..  20:587-591. 2002
  • Expression of exogenous protein in the egg white of transgenic chickens..  20:396-399. 2002
  • Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing..  20:47-52. 2002
  • Training physicians for careers in clinical research: a tailored educational experience..  20:99-100. 2002
  • Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer..  19:342-347. 2001
  • Suppression of a P450 hydroxylase gene in plant trichome glands enhances natural-product-based aphid resistance..  19:371-374. 2001
  • Fingerprinting polysaccharides with single-molecule atomic force microscopy..  19:258-262. 2001
  • Erratum: Spliceosome-mediated RNA trans-splicing as a tool for gene therapy (Nature Biotechnol. (1999) 17 (246-252)).  19:277. 2001
  • Antibody-based nanoprobe for measurement of a fluorescent analyte in a single cell..  18:764-767. 2000
  • The use of single-nucleotide polymorphism maps in pharmacogenomics..  18:505-508. 2000
  • High-fidelity mRNA amplification for gene profiling..  18:457-459. 2000
  • Purification of recombinant proteins by fusion with thermally-responsive polypeptides..  17:1112-1115. 1999
  • Noninvasive visualization of tumors in rodent dorsal skin window chambers..  17:1033-1035. 1999
  • Directed evolution of the surface chemistry of the reporter enzyme beta-glucuronidase..  17:696-701. 1999
  • Spliceosome-mediated RNA trans-splicing as a tool for gene therapy..  17:246-252. 1999
  • Erratum: Spliceosome-mediated RNA trans-splicing as a tool for gene therapy (Nature Biotechnology).  17:602. 1999
  • Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA..  16:364-369. 1998
  • Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa..  15:965-970. 1997
  • Evaluating and enhancing ribozyme reaction efficiency in mammalian cells..  15:902-905. 1997
  • Stress is good and bad for tumors..  15:722-723. 1997
  • Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies..  15:41-45. 1997
  • G protein-coupled receptors and receptor kinases: from molecular biology to potential therapeutic applications..  14:283-286. 1996